Free shipping on all orders over $ 500

 About 9 results found for searched term "82-89-3" (1.225 seconds)

Cat.No.  Name Target
M1512 Nimotuzumab EGFR/HER2
CAS# 780758-10-3
Nimotuzumab (Nimotuzumab) is the first humanized monoclonal antibody targeting epidermal growth factor receptor (EGFR). Nimotuzumab has cytolytic effects on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). Nimotuzumab failed to recognize mouse EGFR.
M9043 INCB057643 Epigenetic Reader Domain
INCB057643 is a novel BET inhibitor.
M9075 Etomoxir sodium salt Apoptosis
(R)-(+)-Etomoxir sodium salt
Etomoxir((R)-(+)-Etomoxir) sodium salt is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig.
M10898 Prodigiosin Antibiotic
Prodigiosine; NSC47147
Prodigiosin (Prodigiosine), a natural red pigment, is a biologically active secondary metabolite. Prodigiosin is a potent inhibitor of the Wnt/β-catenin pathway. Prodigiosin has antibacterial, antifungal, antiprotozoal, antimalarial, immunosuppressive and anti-cancer properties.
M16201 Indigo Alkaloids
Indigo
M17662 3-Oxo-24,25,26,27- tetranortirucall-7-en-23,21-olide Triterpenoids
3-Oxo-24,25,26,27- tetranortirucall-7-en-23,21-olide
M20944 Metronidazole Benzoate Anti-infection
Benzoyl metronidazole
Metronidazole Benzoate is the benzoate ester of metronidazole, a synthetic nitroimidazole derivative with antiprotozoal and antibacterial activities.
M21855 Ansatrienin A Others
Mycotrienin I
Ansatrienin A
M39177 2,3-Dihydroisoginkgetin Tyrosinase
2,3-Dihydroisoginkgetin, a biflavonoid, is a inhibitor of Tyrosinase, with 36.84% inhibition at 0.1 mM. 2,3-Dihydroisoginkgetin shows less toxicity in HEMn (human epidermal melanocytes) cells, with an IC50 of 86.16 μM.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.